✦ LIBER ✦

PCV130 EVALUATION ON THE DRUGS AND MEDICAL COST OF PATIENTS WITH HYPERTENSION IN CHINA

✍ Scribed by X Xiong; L Yao; X Yan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV79 THE COST-EFFECTIVENESS OF IRBESART

✍ S Hu; W Chen; L Annemans 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Consequences, measurement, and evaluatio

✍ Qing-ping, Shi; Xiao-dong, Jiang; Feng, Ding; Yan, Liu; Mei-ling, Yu; Jin-xiu, Z 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 203 KB

PCV152 TREATMENT PATTERNS, RESOURCE UTIL

✍ M Angalakuditi; E Buysman; T Bancroft; A Beardsworth 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

PCV11 EFFECTS OF MEDICATION SUPPLY ON HE

✍ Sruamsiri, R; Dilokthornsakul, P; Nimpitakpong, P; Jeanpeerapong, N; Chaiyakunap 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PCV73 COST–ANALYSIS OF STROKE PATIENTS W

✍ MJ Ku; EK Lee 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PCV32 COST-EFFECTIVENESS OF IRBESARTAN I

✍ H Hernandez; L Lepe; A Gonzalez; A Lemus 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB